Sidebar Navigation

Vaccine Recommendations by AOR

For general policy guidance on every vaccine, please see the Joint Regulation on Immunizations and Chemoprophylaxis for the Prevention of Infectious Diseases (AR 40-562, BUMEDINST 6230.15B, AFI 48-110_IP, CG COMDTINST M6230.4G).

Travel Alerts

Travel notices are designed to inform travelers and clinicians about current health issues related to specific destinations. These issues may arise from disease outbreaks, special events or gatherings, natural disasters, or other conditions that may affect travelers’ health. >>View current and ongoing travel alerts

Click here for a high-resolution copy of the map below.

USAFRICOM

Vaccine	Administration	Required for AFRICOM
Chickenpox	Schedule: 0, 4-8w (2 dose) or + serologic testing Route: Subcutaneous Dose: 0.5ml	Required.
Hepatitis A	Schedule: 0, 6m (2 dose) or + serologic testing Route: Intramuscular Dose: 1-18 years, 0.5ml; >=19 years, 1 ml; Twinrix >=18 years, 1ml	Required.
Hepatitis B	Schedule: Engerix-B, Recombivax, Twinrix: 0,1,6m (3 dose)or Heplisav-B: 0,1m (2 dose) or + serologic testing Route: Intramuscular Dose: Engerix-B or Recombivax: 0-19 years, 0.5ml; >=20 years, 1 ml; Twinrix >=18 years, 1ml; Heplisav-B >=18 years, 0.5mL	Required.
Influenza - Seasonal	Schedule: 1 dose annually Route: Intramuscular, Intranasal Dose: IM 0.5ml; Intranasal 0.2ml	Required.
M-M-R	Schedule: 2 lifetime doses or + serologic testing Route: Subcutaneous Dose: 0.5ml	Required.
Meningococcal	Schedule: If at prolonged risk of disease exposure, vaccinate every 5 yrs. Route: Menomune, Subcutaneous; Menactra and Menveo, Intramuscular Dose: 0.5ml	Required.
Pneumococcal	Schedule: High risk: 1 dose, Asplenic Only: 1 dose + 1 time booster if 5 yrs or greater since 1st dose Route: Subcutaneous or Intramuscular Dose: 0.5ml	Required for high risk health conditions per ACIP.
Polio	Schedule: 1 dose as adult Route: Subcutaneous or Intramuscular Dose: 0.5ml	Required. See additional guidance for travel to and from USAFRICOM countries affected by polio. See also Interim CDC Guidance for Travel to high risk countries.
Rabies	Schedule: Pre-Exposure: 0,7,(21 or 28d) Booster: 2-5 yr (when titer drops >1:5) Route: Intramuscular Dose: 1ml	Required for personnel at high risk for exposure IAW Service-Specific guidelines.
Tdap	Schedule: 1 lifetime dose of Tdap, Td boosters every 10 yrs. For adults who previously have not received a dose of Tdap, 1 dose should be given regardless of interval since last tetanus vaccine. Route: Intramuscular (Tdap, Td, Tetanus Toxoid) Dose: 0.5ml (Tdap, Td, Tetanus Toxoid)	Required.
Typhoid	Schedule: Injectable: every 2 yr; Oral: every 5 yr Route: Intramuscular or Oral Dose: IM 0.5ml; Oral, 4 capsules (day 1,3,5,7)	Required.
Yellow Fever	Schedule: 1 lifetime dose. Must be administered 10 days prior to travel. Route: Subcutaneous Dose: 0.5ml	Required except for Comoros, Morocco and Tunisia. All YF vaccinations must be documented on a CDC 731. See exception for Ascension Island.

USCENTCOM

Vaccine	Administration	Required for CENTCOM
Anthrax	Schedule: 0,4w,6,12,18m + annual booster Route: Intramuscular Dose: 0.5ml	Required for 15 or more days in theater.
Chickenpox	Schedule: 0, 4-8w (2 dose) or + serologic testing Route: Subcutaneous Dose: 0.5ml	Required. Documentation must include one of the following: Born before 1980, history of disease, sufficient varicella titer, or administration of vaccine.
Hepatitis A	Schedule: 0, 6m (2 dose) or + serologic testing Route: Intramuscular Dose: 1-18 years, 0.5ml; >=19 years, 1 ml; Twinrix >=18 years, 1ml	Required.
Hepatitis B	Schedule: Engerix-B, Recombivax, Twinrix: 0,1,6m (3 dose)or Heplisav-B: 0,1m (2 dose) or + serologic testing Route: Intramuscular Dose: Engerix-B or Recombivax: 0-19 years, 0.5ml; >=20 years, 1 ml; Twinrix >=18 years, 1ml; Heplisav-B >=18 years, 0.5mL	Required.
Influenza - Seasonal	Schedule: 1 dose annually Route: Intramuscular, Intranasal Dose: IM 0.5ml; Intranasal 0.2ml	Required.
M-M-R	Schedule: 2 lifetime doses or + serologic testing Route: Subcutaneous Dose: 0.5ml	Required. Documentation must include one of the following: Born before 1957, effective immunity by titer, or administration of two lifetime doses.
Pneumococcal	Schedule: High risk: 1 dose, Asplenic Only: 1 dose + 1 time booster if 5 yrs or greater since 1st dose Route: Subcutaneous or Intramuscular Dose: 0.5ml	Required for high risk health conditions per ACIP.
Polio	Schedule: 1 dose as adult Route: Subcutaneous or Intramuscular Dose: 0.5ml	For individuals traveling for > 4 weeks, vaccination required to be administered within 12 months of DEPARTURE FROM Afghanistan and Pakistan.
Rabies	Schedule: Pre-Exposure: 0,7,(21 or 28d) Booster: 2-5 yr (when titer drops >1:5) Route: Intramuscular Dose: 1ml	Required for personnel at high risk for exposure IAW Service-Specific guidelines.
Tdap	Schedule: 1 lifetime dose of Tdap, Td boosters every 10 yrs. For adults who previously have not received a dose of Tdap, 1 dose should be given regardless of interval since last tetanus vaccine. Route: Intramuscular (Tdap, Td, Tetanus Toxoid) Dose: 0.5ml (Tdap, Td, Tetanus Toxoid)	Required.
Typhoid	Schedule: Injectable: every 2 yr; Oral: every 5 yr Route: Intramuscular or Oral Dose: IM 0.5ml; Oral, 4 capsules (day 1,3,5,7)	Required.

USEUCOM

Vaccine	Administration	Required for EUCOM
Chickenpox	Schedule: 0, 4-8w (2 dose) or + serologic testing Route: Subcutaneous Dose: 0.5ml	Required.
Hepatitis A	Schedule: 0, 6m (2 dose) or + serologic testing Route: Intramuscular Dose: 1-18 years, 0.5ml; >=19 years, 1 ml; Twinrix >=18 years, 1ml	Required.
Hepatitis B	Schedule: Engerix-B, Recombivax, Twinrix: 0,1,6m (3 dose)or Heplisav-B: 0,1m (2 dose) or + serologic testing Route: Intramuscular Dose: Engerix-B or Recombivax: 0-19 years, 0.5ml; >=20 years, 1 ml; Twinrix >=18 years, 1ml; Heplisav-B >=18 years, 0.5mL	Required.
Influenza - Seasonal	Schedule: 1 dose annually Route: Intramuscular, Intranasal Dose: IM 0.5ml; Intranasal 0.2ml	Required.
M-M-R	Schedule: 2 lifetime doses or + serologic testing Route: Subcutaneous Dose: 0.5ml	Required.
Meningococcal	Schedule: If at prolonged risk of disease exposure, vaccinate every 5 yrs. Route: Menomune, Subcutaneous; Menactra and Menveo, Intramuscular Dose: 0.5ml	Specific countries only - See NCMI recommendations.
Pneumococcal	Schedule: High risk: 1 dose, Asplenic Only: 1 dose + 1 time booster if 5 yrs or greater since 1st dose Route: Subcutaneous or Intramuscular Dose: 0.5ml	Required for high risk health conditions per ACIP.
Polio	Schedule: 1 dose as adult Route: Subcutaneous or Intramuscular Dose: 0.5ml	Required.
Rabies	Schedule: Pre-Exposure: 0,7,(21 or 28d) Booster: 2-5 yr (when titer drops >1:5) Route: Intramuscular Dose: 1ml	Required for personnel at high risk for exposure IAW Service-Specific guidelines.
Tdap	Schedule: 1 lifetime dose of Tdap, Td boosters every 10 yrs. For adults who previously have not received a dose of Tdap, 1 dose should be given regardless of interval since last tetanus vaccine. Route: Intramuscular (Tdap, Td, Tetanus Toxoid) Dose: 0.5ml (Tdap, Td, Tetanus Toxoid)	Required.
Typhoid	Schedule: Injectable: every 2 yr; Oral: every 5 yr Route: Intramuscular or Oral Dose: IM 0.5ml; Oral, 4 capsules (day 1,3,5,7)	Required for countries with intermediate or high risk per NCMI, to include: Albania, Georgia, Israel, Kosovo, Macedonia, Moldova, Montenegro, Romania, Russia, Serbia, Turkey and Ukraine.
Yellow Fever	Schedule: 1 lifetime dose. Must be administered 10 days prior to travel. Route: Subcutaneous Dose: 0.5ml	Specific countries only - See YF vaccine transiting requirements.

USINDOPACOM

Vaccine	Administration	Required for INDOPACOM
Anthrax	Schedule: 0,4w,6,12,18m + annual booster Route: Intramuscular Dose: 0.5ml	Required for travel of 15 days or longer to Korea, to include forward deployed naval forces. Three-dose primary series required for III MEF. All others per DoD policy.
Chickenpox	Schedule: 0, 4-8w (2 dose) or + serologic testing Route: Subcutaneous Dose: 0.5ml	Required.
Hepatitis A	Schedule: 0, 6m (2 dose) or + serologic testing Route: Intramuscular Dose: 1-18 years, 0.5ml; >=19 years, 1 ml; Twinrix >=18 years, 1ml	Required.
Hepatitis B	Schedule: Engerix-B, Recombivax, Twinrix: 0,1,6m (3 dose)or Heplisav-B: 0,1m (2 dose) or + serologic testing Route: Intramuscular Dose: Engerix-B or Recombivax: 0-19 years, 0.5ml; >=20 years, 1 ml; Twinrix >=18 years, 1ml; Heplisav-B >=18 years, 0.5mL	Required.
Influenza, Northern Hemisphere (NH)	Schedule: 1 dose annually Route: Intramuscular, Intranasal Dose: IM 0.5ml; Intranasal 0.2ml	Required if you are residing in / traveling to a designated NH vaccine country by the WHO for 14 or more days from October through March.
Influenza, Southern Hemisphere (SH)	Schedule: 1 dose annually Route: Intramuscular Dose: IM 0.5ml	Required if you are residing in / traveling to a designated SH vaccine country by the WHO for 14 or more days from April through September.
Japanese encephalitis	Schedule: 0,28 d (2 dose). One-time booster dose if >11 months after series complete and still in endemic area. Route: Intramuscular Dose: 0.5ml	Required for the following countries and groups: Korea, SOF and III MEF. Required in Japan for PACFLT and USAF in addition to those previously listed. Recommended for all others.
M-M-R	Schedule: 2 lifetime doses or + serologic testing Route: Subcutaneous Dose: 0.5ml	Required.
Pneumococcal	Schedule: High risk: 1 dose, Asplenic Only: 1 dose + 1 time booster if 5 yrs or greater since 1st dose Route: Subcutaneous or Intramuscular Dose: 0.5ml	Required for high risk health conditions per ACIP.
Polio	Schedule: 1 dose as adult Route: Subcutaneous or Intramuscular Dose: 0.5ml	Required. In the setting of a polio outbreak, comply with CDC or WHO recommendations and if in-country deployment is > 4 weeks, vaccination is required prior to arriving in country.
Rabies	Schedule: Pre-Exposure: 0,7,(21 or 28d) Booster: 2-5 yr (when titer drops >1:5) Route: Intramuscular Dose: 1ml	Required for personnel at high risk for exposure IAW Service-Specific guidelines
Smallpox	Schedule: 1 dose, every 10 yr Route: 15 percutaneous jabs for primary and re-vaccinees, over deltoid.	Required for travel of 15 days or longer to Korea, to include forward deployed naval forces. Required for III MEF. All others per DoD policy.
Tdap	Schedule: 1 lifetime dose of Tdap, Td boosters every 10 yrs. For adults who previously have not received a dose of Tdap, 1 dose should be given regardless of interval since last tetanus vaccine. Route: Intramuscular (Tdap, Td, Tetanus Toxoid) Dose: 0.5ml (Tdap, Td, Tetanus Toxoid)	Required.
Typhoid	Schedule: Injectable: every 2 yr; Oral: every 5 yr Route: Intramuscular or Oral Dose: IM 0.5ml; Oral, 4 capsules (day 1,3,5,7)	Required for Korea, III MEF and Operational Forces. All others per DoD policy.
Yellow Fever	Schedule: 1 lifetime dose. Must be administered 10 days prior to travel. Route: Subcutaneous Dose: 0.5ml	Required only for entry into some USINDOPACOM countries (per CDC Yellow Book) if traveling from, or transiting through, endemic areas (Africa & South America). CDC 731 Stamp required.

USNORTHCOM

Vaccine	Administration	Academies - ROTC	Coast Guard	Initial Entry Training	Service members in USA
Anthrax	Schedule: 0,4w,6,12,18m + annual booster Route: Intramuscular Dose: 0.5ml	N/A	Per USCG Policy.	N/A	Per DoD Policy.
Chickenpox	Schedule: 0, 4-8w (2 dose) or + serologic testing Route: Subcutaneous Dose: 0.5ml	Required.	Required.	Required.	Required.
Hepatitis A	Schedule: 0, 6m (2 dose) or + serologic testing Route: Intramuscular Dose: 1-18 years, 0.5ml; >=19 years, 1 ml; Twinrix >=18 years, 1ml	Required.	Required.	Required.	Required.
Hepatitis B	Schedule: Engerix-B, Recombivax, Twinrix: 0,1,6m (3 dose)or Heplisav-B: 0,1m (2 dose) or + serologic testing Route: Intramuscular Dose: Engerix-B or Recombivax: 0-19 years, 0.5ml; >=20 years, 1 ml; Twinrix >=18 years, 1ml; Heplisav-B >=18 years, 0.5mL	Required.	Required.	Required.	Per DoD Policy.
Influenza - Seasonal	Schedule: 1 dose annually Route: Intramuscular, Intranasal Dose: IM 0.5ml; Intranasal 0.2ml	Required.	Required.	Required.	Required.
M-M-R	Schedule: 2 lifetime doses or + serologic testing Route: Subcutaneous Dose: 0.5ml	Required.	Required.	Required.	Required.
Meningococcal	Schedule: If at prolonged risk of disease exposure, vaccinate every 5 yrs. Route: Menomune, Subcutaneous; Menactra and Menveo, Intramuscular Dose: 0.5ml	Required Academies Only.	N/A	Required.	N/A
Pneumococcal	Schedule: High risk: 1 dose, Asplenic Only: 1 dose + 1 time booster if 5 yrs or greater since 1st dose Route: Subcutaneous or Intramuscular Dose: 0.5ml	N/A	Required for asplenic and other high risk health conditions per ACIP.	San Diego: 1 dose. Parris Island: 1 dose. Cape May: 1 dose.	Required for high risk health conditions per ACIP.
Polio	Schedule: 1 dose as adult Route: Subcutaneous or Intramuscular Dose: 0.5ml	Required.	Required.	Required.	Required.
Rabies	Schedule: Pre-Exposure: 0,7,(21 or 28d) Booster: 2-5 yr (when titer drops >1:5) Route: Intramuscular Dose: 1ml	N/A	Per USCG Policy.	N/A	Required for personnel at high risk for exposure IAW Service-Specific guidelines
Smallpox	Schedule: 1 dose, every 10 yr Route: 15 percutaneous jabs for primary and re-vaccinees, over deltoid.	N/A	Per USCG Policy.	N/A	Per DoD Policy.
Tdap	Schedule: 1 lifetime dose of Tdap, Td boosters every 10 yrs. For adults who previously have not received a dose of Tdap, 1 dose should be given regardless of interval since last tetanus vaccine. Route: Intramuscular (Tdap, Td, Tetanus Toxoid) Dose: 0.5ml (Tdap, Td, Tetanus Toxoid)	Required.	Required.	Required.	Required.
Typhoid	Schedule: Injectable: every 2 yr; Oral: every 5 yr Route: Intramuscular or Oral Dose: IM 0.5ml; Oral, 4 capsules (day 1,3,5,7)	N/A	Per USCG Policy.	N/A	Per NORAD & USNORTHCOM Instruction 44-163.

USSOUTHCOM

Vaccine	Administration	Required for SOUTHCOM (includes Haiti)
Chickenpox	Schedule: 0, 4-8w (2 dose) or + serologic testing Route: Subcutaneous Dose: 0.5ml	Required.
Hepatitis A	Schedule: 0, 6m (2 dose) or + serologic testing Route: Intramuscular Dose: 1-18 years, 0.5ml; >=19 years, 1 ml; Twinrix >=18 years, 1ml	Required.
Hepatitis B	Schedule: Engerix-B, Recombivax, Twinrix: 0,1,6m (3 dose)or Heplisav-B: 0,1m (2 dose) or + serologic testing Route: Intramuscular Dose: Engerix-B or Recombivax: 0-19 years, 0.5ml; >=20 years, 1 ml; Twinrix >=18 years, 1ml; Heplisav-B >=18 years, 0.5mL	Required.
Influenza - Seasonal	Schedule: 1 dose annually Route: Intramuscular, Intranasal Dose: IM 0.5ml; Intranasal 0.2ml	Required.
M-M-R	Schedule: 2 lifetime doses or + serologic testing Route: Subcutaneous Dose: 0.5ml	Required.
Pneumococcal	Schedule: High risk: 1 dose, Asplenic Only: 1 dose + 1 time booster if 5 yrs or greater since 1st dose Route: Subcutaneous or Intramuscular Dose: 0.5ml	Required for high risk health conditions per ACIP.
Polio	Schedule: 1 dose as adult Route: Subcutaneous or Intramuscular Dose: 0.5ml	Required.
Rabies	Schedule: Pre-Exposure: 0,7,(21 or 28d) Booster: 2-5 yr (when titer drops >1:5) Route: Intramuscular Dose: 1ml	Required for personnel at high risk for exposure IAW Service-Specific guidelines.
Tdap	Schedule: 1 lifetime dose of Tdap, Td boosters every 10 yrs. For adults who previously have not received a dose of Tdap, 1 dose should be given regardless of interval since last tetanus vaccine. Route: Intramuscular (Tdap, Td, Tetanus Toxoid) Dose: 0.5ml (Tdap, Td, Tetanus Toxoid)	Required.
Typhoid	Schedule: Injectable: every 2 yr; Oral: every 5 yr Route: Intramuscular or Oral Dose: IM 0.5ml; Oral, 4 capsules (day 1,3,5,7)	Required.
Yellow Fever	Schedule: 1 lifetime dose. Must be administered 10 days prior to travel. Route: Subcutaneous Dose: 0.5ml	Required for countries where the disease is endemic, per the CDC. Required if traveling from an endemic area to those countries with transiting requirements (per WHO) and per USSOUTHCOM memo dated November 28, 2018.

Regional Vaccine Recommendations provided for informational reference purposes only.
Always vaccinate according to package inserts and DoD/Service guidelines.

Page last updated: December 10, 2018

You also may be interested in...

Countries with risk of yellow fever transmission and countries requiring yellow fever vaccination

Publication

7/1/2019

Recommended Content:

Yellow Fever | Vaccine Recommendations by AOR

III MEF Force Health Protection Requirements 2019

Policy

Identification #: N/A
Date: 2/1/2019
Type: Directives
Topics: Vaccine-Preventable Diseases | Vaccine Recommendations by AOR

Immunization Recommendations for Disaster Response Operations

Fact Sheet

8/30/2017

This information paper provides immunization recommendations and resources for Department of Defense (DoD) personnel supporting disaster response operations, both in CONUS and OCONUS.

Recommended Content:

Japanese Encephalitis Surveillance and Immunization — Asia and Western Pacific Regions, 2016

Report

6/9/2017

A review of surveillance and immunization program data in the 24 countries with JE virus transmission risk found that in 2016, 22 countries conducted at least some surveillance for JE, and 12 had implemented a JE immunization program.

Recommended Content:

Japanese Encephalitis | Vaccine Recommendations by AOR

MMQC-16-2312 Yellow Fever Vaccine Limited Supply and Ordering Restrictions

Publication

12/20/2016

Recommended Content:

Yellow Fever | Vaccine Recommendations by AOR

AF-SG3-5 Memo - Clarification of Air Force Mumps Vaccination Guidance

Policy

Identification #: N/A
Date: 11/30/2016
Type: Guidelines
Topics: Measles-Mumps-Rubella | Vaccine Recommendations by AOR

COMPACFLT Guidance on the Japanese Encephalitis Vaccine for U.S. Navy Personnel and TRICARE beneficiaries in the Pacific Fleet Area of Responsibility

Policy

Identification #: N/A
Date: 11/1/2016
Type: Instructions
Topics: Japanese Encephalitis | Vaccine Recommendations by AOR

Guidance on the Japanese Encephalitis Vaccine for US Army Personnel in the Pacific Area of Responsibility

Policy

Guidance on the Japanese Encephalitis Vaccine for US Army Personnel in the Pacific Area of Responsibility

Identification #: OTSG/MEDCOM Policy Memo 15-059
Date: 12/1/2015
Type: Memorandums
Topics: Japanese Encephalitis | Vaccine Recommendations by AOR

International Certificate of Vaccination or Prophylaxis

Publication

6/15/2007

Recommended Content:

Yellow Fever | Vaccine Recommendations by AOR

Showing results 1 - 9 Page 1 of 1

Utility Navigation Links

Social Media Links

Photos

Videos

Infographics

Sidebar Navigation

Leadership Bios

Leadership Bios

U.S. Africa Command

U.S. Central Command

U.S. European Command

Leadership Bios

U.S. Indo-Pacific Command

U.S. Northern Command

U.S. Southern Command

Vaccine Recommendations by AOR

USAFRICOM

USCENTCOM

USEUCOM

USINDOPACOM

USNORTHCOM

USSOUTHCOM

Page last updated: December 10, 2018

You also may be interested in...

Countries with risk of yellow fever transmission and countries requiring yellow fever vaccination

III MEF Force Health Protection Requirements 2019

Immunization Recommendations for Disaster Response Operations

Japanese Encephalitis Surveillance and Immunization — Asia and Western Pacific Regions, 2016

MMQC-16-2312 Yellow Fever Vaccine Limited Supply and Ordering Restrictions

AF-SG3-5 Memo - Clarification of Air Force Mumps Vaccination Guidance

COMPACFLT Guidance on the Japanese Encephalitis Vaccine for U.S. Navy Personnel and TRICARE beneficiaries in the Pacific Fleet Area of Responsibility

Guidance on the Japanese Encephalitis Vaccine for US Army Personnel in the Pacific Area of Responsibility

International Certificate of Vaccination or Prophylaxis